Clinical Trials Logo

Respiration, Artificial clinical trials

View clinical trials related to Respiration, Artificial.

Filter by:

NCT ID: NCT03439683 Recruiting - Clinical trials for Respiratory Insufficiency

KAP Asynchrony Survey

KAPA
Start date: March 26, 2018
Phase:
Study type: Observational

The investigators developed a web-based survey to assess knowledge, attitudes and practice of health care professionals about patient-ventilator asynchrony.

NCT ID: NCT03181620 Recruiting - Postoperative Pain Clinical Trials

Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation

SATIRE
Start date: September 8, 2016
Phase: N/A
Study type: Interventional

SATIRE is a prospective, randomized control trial assessing two methods of administration of intravenous sedation and narcotics in surgical patients requiring mechanical ventilation. Many hospitals use a continuous infusion method of administering these medications. The investigators hypothesize that intermittent, bolus/sliding-scale based administration will lead to less medication being given and subsequently decrease the amount of time on mechanical ventilation without compromising patient comfort or level of sedation. Patients are randomized into a control arm (continuous infusion) and a trial arm (sliding scale hourly bolus) using versed for sedation and fentanyl for pain medication. Inclusion criteria are surgical patients requiring mechanical ventilation, including trauma patients, post operative patients, etc. Primary end point is total time of mechanical ventilation in each arm. Secondary end points are amount of medication given, time in ICU, time to discharge. Mortality and adverse events in both arms are recorded and reported to the Institutional Review Board for monitoring.

NCT ID: NCT02842944 Recruiting - Clinical trials for Respiration, Artificial

Weaning From Mechanical Ventilation Comparison of Open-loop Decision Support System and Routine Care

BEACON
Start date: December 12, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to compare mechanical ventilation following advice from the Beacon Caresystem to that of routine care in patients from the state of requiring invasive mechanical ventilation until successful extubation. The Beacon Caresystem will be compared to routine care to investigate whether use of the system results in similar care and reduced time for weaning from mechanical ventilation.

NCT ID: NCT02703285 Recruiting - Clinical trials for Respiration, Artificial

Are Medical Personnel Can Correctly Recognize the Chest Sounds?

Start date: February 2016
Phase: N/A
Study type: Interventional

The study aims to validate the interpretation of breath sounds by medical personnel

NCT ID: NCT01193023 Recruiting - Clinical trials for Respiration, Artificial

Patient-ventilator Asynchrony During Mechanical Invasive Assisted-ventilation in Pediatric Patients

NavPed-Inv
Start date: June 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to document the prevalence and type of asynchronies incidence during invasive mechanical ventilation in pediatric patients breathing under pressure support. And to observe the impact of adjusting the expiratory trigger setting on asynchronies, and compare these incidences with asynchronies measured in pediatric patient breathing under NAVA system (Neurally Adjusted Ventilatory Assist).

NCT ID: NCT01165528 Recruiting - Clinical trials for Respiratory Distress Syndrome, Adult

Adaptive Support Ventilation in Acute Respiratory Distress Syndrome (ARDS)

Start date: January 2010
Phase: N/A
Study type: Interventional

Prospective randomized controlled trial to be conducted in the Respiratory Intensive Care Unit (RICU) of Post Graduate Institute of Medical Education And Research (PGIMER),Chandigarh. The study is approved by the Institute Ethics committee. In view of lack of previous outcome data in such patients, all patients requiring RICU admission for acute respiratory distress syndrome(ARDS) between January 2010 and June 2011 are being enrolled in this pilot study. The patients meeting the aforementioned criteria will randomly assigned to ventilation with assist control mode ventilation (ACMV group) as per the ARDSnet strategy or adaptive support ventilation (ASV group). Being the first RCT of its type, patients will be first stabilized on ACMV for 1 hour to determine the adequate minute ventilation. The randomization sequence will be computer generated. The assignments will placed in sealed opaque envelopes and each patient's assignment was made on admission to the RICU by the attending physician. Blinding of treatment is not possible. All patients will be ventilated only by Galileo Gold ventilators (Hamilton medical systems, Bonaduz, Switzerland). Patients randomized to the ACMV group will be ventilated according to low tidal volume strategy of 6ml/kg with Fio2/PEEP as per ARDSnet table to achieve a saturation between 88-95% with the lowest possible Fio2 to maintain plateau pressures < 30 cms H2o and PH > 7.3 with option to reduce tidal volume to 4 ml/kg and increase respiratory rate to 35/ min to achieve the above said goals11.These patients will be weaned as per standard protocol of spontaneous breathing trial of 30 minutes once they are recognized eligible as per statement of the sixth International consensus conference on weaning.

NCT ID: NCT00911378 Recruiting - Clinical trials for Respiration, Artificial

Pressure Support Reduction Versus Spontaneous Breathing Trials in Weaning From Ventilation

Start date: April 2008
Phase: N/A
Study type: Interventional

This study is a comparison of two most commonly used modes of weaning and the outcomes in the two groups.

NCT ID: NCT00196469 Recruiting - Hemorrhage Clinical Trials

Impact of Heparin on the Need for Mechanical Ventilation in Neonates

Start date: December 2003
Phase: Phase 4
Study type: Interventional

This study is designed to test an incidental finding of a previous trial in which post hoc analysis showed that the rate of intensive care newborns requiring mechanical ventilation was lower in the group receiving heparin with the continuous infusion as compared to the placebo group.